Actinogen Medical (ASX:ACW) Accounts Payable : A$2.03 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Accounts Payable?

Actinogen Medical's Accounts Payable for the quarter that ended in Dec. 2023 was A$2.03 Mil.

Actinogen Medical's quarterly Accounts Payable declined from Dec. 2022 (A$1.49 Mil) to Jun. 2023 (A$1.10 Mil) but then increased from Jun. 2023 (A$1.10 Mil) to Dec. 2023 (A$2.03 Mil).

Actinogen Medical's annual Accounts Payable increased from Jun. 2021 (A$0.39 Mil) to Jun. 2022 (A$0.90 Mil) and increased from Jun. 2022 (A$0.90 Mil) to Jun. 2023 (A$1.10 Mil).

Actinogen Medical Accounts Payable Historical Data

The historical data trend for Actinogen Medical's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Accounts Payable Chart

Actinogen Medical Annual Data

Trend

Jun13

Jun14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable

Get a 7-Day Free Trial

0.28

0.05

0.39

0.90

1.10

Actinogen Medical Semi-Annual Data
	Dec13	Jun14	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															0.81	0.90	1.49	1.10	2.03

Actinogen Medical Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Actinogen Medical Accounts Payable Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Actinogen Medical (ASX:ACW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

3AC:Germany

Address

109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000

Website

https://www.actinogen.com.au

Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.

Actinogen Medical (ASX:ACW) Headlines

From GuruFocus

Accuride Corporation: Earnings Report For Q2 2014

By Black Iguana Nitish • 10-13-2014

Stocks That Are Making A Good Come Back

By reports.droy reports.droy • 03-10-2015